Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables RefundsShares Repurchased
Ratios

Biote (BTMD) EBIAT (2021 - 2025)

Biote (BTMD) has 3 years of EBIAT data on record, last reported at $9.1 million in Q4 2023.

  • For Q4 2023, EBIAT rose 461.84% year-over-year to $9.1 million; the TTM value through Dec 2023 reached -$19.3 million, down 90.85%, while the annual FY2024 figure was $3.2 million, 4.79% down from the prior year.
  • EBIAT reached $9.1 million in Q4 2023 per BTMD's latest filing, up from $6.1 million in the prior quarter.
  • Across five years, EBIAT topped out at $9.8 million in Q2 2021 and bottomed at -$21.4 million in Q1 2023.
  • Average EBIAT over 3 years is -$1.5 million, with a median of $3.8 million recorded in 2022.
  • The widest YoY moves for EBIAT: up 40360.0% in 2023, down 329.2% in 2023.
  • A 3-year view of EBIAT shows it stood at -$16.0 million in 2021, then skyrocketed by 110.12% to $1.6 million in 2022, then soared by 461.84% to $9.1 million in 2023.
  • Per Business Quant database, its latest 3 readings for EBIAT were $9.1 million in Q4 2023, $6.1 million in Q3 2023, and -$13.1 million in Q2 2023.